We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Merge Engages New York Investment Bank to Explore, Assess Strategic Options

By MedImaging International staff writers
Posted on 11 Sep 2012
Print article
Merge Healthcare, Inc. (Chicago, IL, USA), a leading provider of clinical systems, announced that its board of directors has retained Allen & Company, LLC (New York, NY, USA) investment bank, to help in investigating and evaluating a wide range of strategic alternatives, including (but not limited to), a sale of the company or a business combination.

Merge does not have a distinct timeline for the strategic review, and there is no guarantee that the review will result in any specific action or transaction. Company spokespersons stated that they are not commenting further regarding the evaluation of strategic alternatives, unless a definitive agreement for a specific transaction is entered into, the process is concluded, or it otherwise considers additional disclosure is suitable or required.

Merge’s enterprise and cloud-based solutions for image-intensive specialties provide access to any image, anywhere, any time. Moreover, Merge develops health stations, clinical trials software, and other health data and analytics systems that engage consumers in their personal health.

Related Links:

Merge
Allen & Company



New
Biopsy Software
Affirm® Contrast
Digital X-Ray Detector Panel
Acuity G4
Computed Tomography System
Aquilion ONE / INSIGHT Edition
Portable X-ray Unit
AJEX140H

Print article

Channels

Radiography

view channel
Image: AI can identify “mammographically-visible” types of interval cancers earlier by flagging them at the time of screening (Photo courtesy of ScreenPoint Medical)

AI Improves Early Detection of Interval Breast Cancers

Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.